Filters
Other countries
Results: 1 to 20 of 20
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Invitae Neurodevelopmental Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 404 | 241 |
|
Invitae Overgrowth Syndromes Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 96 | 53 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 638 | 419 |
|
Autism Spectrum Disorders (ASD) Panel PreventionGenetics, part of Exact Sciences United States | 224 | 170 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Top 99 Genetic Causes of Developmental Delay Panel PreventionGenetics, part of Exact Sciences United States | 170 | 99 |
|
Overgrowth and Macrocephaly Syndromes Panel PreventionGenetics, part of Exact Sciences United States | 145 | 112 |
|
Autism Spectrum Disorders via the CHD8 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 26 | 68 |
|
Macrocephaly / overgrowth syndrome panel. 43-gene NGS panel. Genologica Medica Spain | 88 | 43 |
|
Autism (susceptiblity to): Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 13 | 12 |
|
Macrocephaly/Overgrowth Syndrome NGS Panel Fulgent Genetics United States | 100 | 38 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5130 | 4674 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Fulgent Genetics United States | 170 | 106 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.